查看購物車
  • Simplified Chinese
  • English
2021-2031 年北美醫療第二意見市場報告（範圍、細分、動態和競爭分析）
市場調查報告書
商品編碼
1843411

2021-2031 年北美醫療第二意見市場報告（範圍、細分、動態和競爭分析）

North America Medical Second Opinion Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 105 Pages | 訂單完成後即時交付

價格

北美醫療第二意見市場預計將大幅成長，到 2031 年將達到約 73.0696 億美元，高於 2023 年的 24.8558 億美元，在此期間的年複合成長率(CAGR) 為 14.4%。

執行摘要和市場分析

北美的醫療二次診療市場主要分為三個區域：美國、加拿大和墨西哥。該市場的成長得益於醫療二次診療服務日益普及以及醫療諮詢領域持續的數位轉型。此外，醫療體系的進步以及對改善治療效果的日益重視預計將進一步推動市場成長。

市場區隔分析

北美醫療第二意見市場可以根據兩個關鍵部分進行分析：醫療條件和服務提供者。

1. 依疾病狀況：市場依各種醫療狀況分類，包括癌症、骨科疾病、心臟疾病、神經系統疾病、腎臟疾病、血液系統疾病、慢性阻塞性肺病 (COPD)、器官移植等。值得注意的是，癌症領域在 2023 年佔據了最大的市場。

2. 按服務提供者分類：市場也按服務提供者細分，包括醫院、健康保險公司和線上服務。 2023年，醫院佔據了最大的市場。

市場展望

在全球範圍內，由於醫療費用上漲，患者面臨越來越大的經濟壓力，而醫療專業人員短缺和資源有限又加劇了這個問題。這種情況催生了對醫療成本最佳化的需求。由於患者希望避免不必要的手術和併發症，對第二醫療意見的需求日益成長。第二醫療意見服務為患者提供全面的資訊，以便他們就治療方案做出明智的決定。這些服務通常包括對病歷的全面審查和替代治療評估，從而可以降低醫療成本並改善患者預後。

研究表明，約有 31% 的患者在手術過程中會出現併發症，每年約有 420 萬人在手術後死亡，這凸顯了第二意見在降低手術相關風險方面的重要性。

國家洞察

北美醫療二次診療意見市場主要由美國推動，美國在2023年佔據了最大的市場佔有率。癌症是美國第二大死亡原因，其發生率的上升為該市場帶來了巨大的成長機會。 2022年，新增癌症病例超過190萬例，導致約609,360人死亡。預計2024年將新增約200萬例癌症病例，將進一步增加對二次診療意見的需求，尤其是在誤診普遍存在的情況下。

此外，美國醫療失誤率極高，每年約有4,000起手術失誤，7,000至9,000例死亡病例歸因於用藥錯誤。每年約有79.5萬美國人因嚴重疾病被誤診，凸顯了醫療保健系統中對第二診療意見的迫切需求。

為了應對這些挑戰，像聯合健康保險 (UnitedHealthcare) 這樣的組織與 2nd.MD 等公司合作，為其會員提供免費的專家醫療意見服務。這項服務將患者與專家聯繫起來，專家會審查他們的病例並提供第二意見。其他組織，例如 WorldCare International Inc.，也為重大疾病提供全面的第二意見服務，涵蓋廣泛的醫療狀況。

公司簡介

北美醫療第二意見市場的主要參與者包括 Second Opinion International、Elite Medical Services、The Cigna Group、Helsana、WorldCare、Vidal Health Insurance TPA Pvt Ltd、2nd.MD、Axa SA、Teladoc Health Inc、Included Health, Inc. 和 Royal Doctors。這些公司正在採用各種策略，包括市場擴張、產品創新和併購，以增強其產品服務並提升其市場佔有率。

目錄

第1章：簡介

第2章：執行摘要

  • 關鍵見解
  • 市場吸引力

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第4章：北美醫療第二意見市場－關鍵市場動態

  • 市場促進因素
    • 越來越重視更好的治療效果
    • 醫療成本最佳化的偏好日益增強
  • 市場限制
    • 新興國家對第二醫療意見缺乏認知且不願採納
  • 市場機會
    • 遠距醫療技術合作日益增多
  • 未來趨勢
    • 醫療諮詢服務數位化
  • 促進因素和限制因素的影響：

第5章：北美醫療第二意見市場－市場分析

  • 2021-2031年北美醫療第二意見市場收入
  • 北美醫療第二意見市場預測分析

第6章：北美醫療第二意見市場分析－依條件

  • 癌症
  • 骨科疾病
  • 心臟疾病
  • 神經系統疾病
  • 腎臟疾病
  • 血液系統疾病
  • 慢性阻塞性肺病
  • 器官移植
  • 其他

第7章：北美醫療第二意見市場分析－依服務供應商

  • 醫院
  • 健康保險公司
  • 線上服務

第8章：北美醫療第二意見市場－國家分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥

第9章：產業格局

  • 概述
  • 市場計劃
  • 夥伴關係與合作

第10章：公司簡介

  • Second Opinion International
  • Elite Medical Services
  • The Cigna Group
  • Helsana
  • WorldCare
  • Vidal Health Insurance TPA Pvt Ltd
  • 2nd.MD
  • Axa SA
  • Teladoc Health Inc
  • Included Health, Inc.
  • Royal Doctors

第 11 章：附錄

Product Code: TIPRE00025159

The North America medical second opinion market is projected to grow significantly, reaching approximately USD 7,306.96 million by 2031, up from USD 2,485.58 million in 2023, with a compound annual growth rate (CAGR) of 14.4% during this period.

Executive Summary and Market Analysis

The medical second opinion market in North America is divided into three main regions: the United States, Canada, and Mexico. The growth of this market is driven by the increasing acceptance of medical second opinion services and the ongoing digital transformation in healthcare consulting. Additionally, advancements in healthcare systems and a heightened focus on improving treatment outcomes are expected to further propel market growth.

Market Segmentation Analysis

The North America medical second opinion market can be analyzed based on two key segments: medical conditions and service providers.

1. By Condition: The market is categorized into various medical conditions, including cancer, orthopedic disorders, cardiac disorders, neurological disorders, nephrological disorders, hematological disorders, chronic obstructive pulmonary disease (COPD), organ transplants, and others. Notably, the cancer segment accounted for the largest market share in 2023.

2. By Service Provider: The market is also segmented by service providers, which include hospitals, health insurance companies, and online services. In 2023, hospitals represented the largest share of the market.

Market Outlook

Globally, patients are facing increasing financial pressures due to rising healthcare costs, which are exacerbated by a shortage of healthcare professionals and limited resources. This situation has created a demand for healthcare cost optimization. The need for second medical opinions is growing as patients seek to avoid unnecessary surgeries and complications. Medical second opinion services provide patients with comprehensive information to make informed decisions regarding their treatment options. These services often involve a thorough review of medical records and alternative treatment assessments, which can lead to reduced healthcare costs and improved patient outcomes.

Research indicates that approximately 31% of patients experience complications from surgical procedures, and around 4.2 million postoperative deaths occur annually, highlighting the importance of second opinions in mitigating risks associated with surgery.

Country Insights

The North American medical second opinion market is primarily driven by the United States, which held the largest market share in 2023. The rising incidence of cancer, which is the second leading cause of death in the U.S., presents significant opportunities for growth in this market. In 2022, over 1.9 million new cancer cases were diagnosed, leading to approximately 609,360 deaths. Projections suggest that around 2 million new cancer cases will be diagnosed in 2024, further increasing the demand for second opinions, especially given the prevalence of misdiagnoses.

Moreover, the U.S. faces a high rate of medical errors, with around 4,000 surgical errors reported annually and 7,000 to 9,000 deaths attributed to medication errors. Approximately 795,000 Americans suffer from misdiagnoses of serious conditions each year, underscoring the critical need for second opinions in the healthcare system.

In response to these challenges, organizations like UnitedHealthcare have partnered with companies such as 2nd.MD to offer no-cost expert medical opinion services to their members. This service connects patients with specialists who review their cases and provide second opinions. Other organizations, such as WorldCare International Inc., also offer comprehensive second opinion services for critical illnesses, covering a wide range of medical conditions.

Company Profiles

Key players in the North America medical second opinion market include Second Opinion International, Elite Medical Services, The Cigna Group, Helsana, WorldCare, Vidal Health Insurance TPA Pvt Ltd, 2nd.MD, Axa SA, Teladoc Health Inc, Included Health, Inc., and Royal Doctors. These companies are employing various strategies, including market expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase their market presence.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:

4. North America Medical Second Opinion Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Growing Emphasis on Better Treatment Outcomes
    • 4.1.2 Increasing Preference for Healthcare Cost Optimization
  • 4.2 Market Restraints
    • 4.2.1 Lack of Awareness and Reluctance Toward Adoption of Medical Second Opinion in Emerging Nations
  • 4.3 Market Opportunities
    • 4.3.1 Rising Collaborations in Telemedicine Technologies
  • 4.4 Future Trends
    • 4.4.1 Digitalization of Medical Consulting Services
  • 4.5 Impact of Drivers and Restraints:

5. North America Medical Second Opinion Market - Market Analysis

  • 5.1 North America Medical Second Opinion Market Revenue (US$ Million), 2021-2031
  • 5.2 North America Medical Second Opinion Market Forecast Analysis

6. North America Medical Second Opinion Market Analysis - by Condition

  • 6.1 Cancer
    • 6.1.1 Overview
    • 6.1.2 Cancer: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.2 Orthopedic Disorders
    • 6.2.1 Overview
    • 6.2.2 Orthopedic Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.3 Cardiac Disorders
    • 6.3.1 Overview
    • 6.3.2 Cardiac Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.4 Neurological Disorders
    • 6.4.1 Overview
    • 6.4.2 Neurological Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.5 Nephrological Disorders
    • 6.5.1 Overview
    • 6.5.2 Nephrological Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.6 Hematological Blood Disorders
    • 6.6.1 Overview
    • 6.6.2 Hematological Blood Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.7 COPD
    • 6.7.1 Overview
    • 6.7.2 COPD: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.8 Organ Transplant
    • 6.8.1 Overview
    • 6.8.2 Organ Transplant: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.9 Others
    • 6.9.1 Overview
    • 6.9.2 Others: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. North America Medical Second Opinion Market Analysis - by Service Provider

  • 7.1 Hospitals
    • 7.1.1 Overview
    • 7.1.2 Hospitals: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Health Insurance Companies
    • 7.2.1 Overview
    • 7.2.2 Health Insurance Companies: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Online Services
    • 7.3.1 Overview
    • 7.3.2 Online Services: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Medical Second Opinion Market - Country Analysis

  • 8.1 North America
    • 8.1.1 North America Medical Second Opinion Market Overview
    • 8.1.2 North America Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
      • 8.1.2.1 North America Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
      • 8.1.2.2 United States: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 8.1.2.2.1 United States: North America Medical Second Opinion Market Share - by Condition
        • 8.1.2.2.2 United States: North America Medical Second Opinion Market Share - by Service Provider
      • 8.1.2.3 Canada: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 8.1.2.3.1 Canada: North America Medical Second Opinion Market Share - by Condition
        • 8.1.2.3.2 Canada: North America Medical Second Opinion Market Share - by Service Provider
      • 8.1.2.4 Mexico: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 8.1.2.4.1 Mexico: North America Medical Second Opinion Market Share - by Condition
        • 8.1.2.4.2 Mexico: North America Medical Second Opinion Market Share - by Service Provider

9. Industry Landscape

  • 9.1 Overview
  • 9.2 Market Initiative
  • 9.3 Partnerships and Collaborations

10. Company Profiles

  • 10.1 Second Opinion International
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Elite Medical Services
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 The Cigna Group
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Helsana
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 WorldCare
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Vidal Health Insurance TPA Pvt Ltd
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 2nd.MD
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Axa SA
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 Teladoc Health Inc
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments
  • 10.10 Included Health, Inc.
    • 10.10.1 Key Facts
    • 10.10.2 Business Description
    • 10.10.3 Products and Services
    • 10.10.4 Financial Overview
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Developments
  • 10.11 Royal Doctors
    • 10.11.1 Key Facts
    • 10.11.2 Business Description
    • 10.11.3 Products and Services
    • 10.11.4 Financial Overview
    • 10.11.5 SWOT Analysis
    • 10.11.6 Key Developments

11. Appendix

  • 11.1 About Us
  • 11.2 List of Abbreviations

List Of Tables

  • Table 1. North America Medical Second Opinion Market Segmentation
  • Table 2. North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Condition
  • Table 4. North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Service Provider
  • Table 5. North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 6. United States: North America Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 7. United States: North America Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 8. Canada: North America Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 9. Canada: North America Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 10. Mexico: North America Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Condition
  • Table 11. Mexico: North America Medical Second Opinion Market - Revenue and Forecast, 2021 - 2031(US$ Million) - by Service Provider
  • Table 12. List of Abbreviations

List Of Figures

  • Figure 1. North America Medical Second Opinion Market Segmentation - Country
  • Figure 2. North America Medical Second Opinion Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Medical Second Opinion Market Revenue (US$ Million), 2021-2031
  • Figure 5. North America Medical Second Opinion Market Share (%) - by Condition (2023 and 2031)
  • Figure 6. Cancer: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Orthopedic Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Cardiac Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Neurological Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Nephrological Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Hematological Blood Disorders: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. COPD: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Organ Transplant: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Others: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. North America Medical Second Opinion Market Share (%) - by Service Provider (2023 and 2031)
  • Figure 16. Hospitals: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Health Insurance Companies: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Online Services: North America Medical Second Opinion Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. North America Medical Second Opinion Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 20. United States: North America Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 21. Canada: North America Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 22. Mexico: North America Medical Second Opinion Market - Revenue and Forecast, 2021- 2031 (US$ Million)